clinical trial · NCT03344003
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
Octapharma·—·terminated·n = 14
Hemophilia AWilate or Nuwiq
brief summary
Uncontrolled, multi-centre, non-interventional study with a prospective and a retrospective cohort, to evaluate the efficacy of Wilate or Nuwiq in achieving complete or partial immune tolerance induction (ITI) success in severe and moderate haemophilia A patients with inhibitors
started
Jun 28, 2018
primary completion
Nov 20, 2020
completion
Nov 20, 2020
last updated
Aug 9, 2024
official title
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq - A Canadian Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol